Jin Lou
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
18 months follow-up of deep molecular response 4.5 (MR4.5) with nilotinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a prospective, multi-center study in China.
Journal: Frontiers in medicine
Published: July 26, 2023
Efficacy and Safety of Generic Dasatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Multicenter Prospective Study in China.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 25, 2022
Chronic myeloid leukemia patients and treatment-free remission attitudes: a multicenter survey.
Journal: Patient preference and adherence
Published: June 27, 2018
CircBA9.3 supports the survival of leukaemic cells by up-regulating c-ABL1 or BCR-ABL1 protein levels.
Journal: Blood cells, molecules & diseases
Published: May 18, 2018
Effect of Myeloma-Derived Exosomes on Surface Activating Receptors of NK Cells
Journal: Zhongguo shi yan xue ye xue za zhi
Published: December 22, 2017
Induction treatments for acute promyelocytic leukemia: a network meta-analysis.
Journal: Oncotarget
Published: May 03, 2016
Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways.
Journal: Molecular medicine reports
Published: December 22, 2014
Construction of protein profile classification model and screening of proteomic signature of acute leukemia.
Journal: International journal of clinical and experimental pathology
Published: July 13, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026